Thymalfasin CAS:69440-99-9

Thymalfasin, or thymosin alpha 1, is utilized in medicine primarily for its immunomodulatory effects. It enhances the function of various immune cells, including T cells, dendritic cells, and natural killer cells, thereby bolstering the body's defense against infections and cancers. Thymalfasin is prescribed to treat chronic viral infections such as hepatitis B and C, as well as for boosting immune function in patients undergoing chemotherapy or with immunodeficiency disorders. Additionally, research indicates its potential in autoimmune diseases and as an adjuvant therapy in cancer treatment, highlighting its broad applicability in clinical settings.